Lorlatinib for the treatment of inflammatory...

Anti-Cancer Drugs 2020 / 11 Vol. 31; Iss. 10

Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib

Wong, Han Hsi, Bentley, Helen, Bulusu, Venkata Ramesh, Anyaegbu, Gloria, Watkins, James, Horan, Gail, Hatcher, Helen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
31
Journal:
Anti-Cancer Drugs
DOI:
10.1097/cad.0000000000000994
Date:
November, 2020
File:
PDF, 467 KB
2020
Conversion to is in progress
Conversion to is failed